Unnati Pharmax continues to serve the Philippines, South Africa, Australia, and Singapore with affordable, WHO-GMP certified antiviral medicines — supporting individuals, community health organisations, and private clinics across all four markets with reliable supply at competitive pricing.
In the Philippines, our Tafero EM for HIV PrEP is increasingly sought by MSM communities in Metro Manila, Cebu, and Davao where HIV incidence among this demographic has risen sharply over the past decade. South Africa's HIV epidemic — the world's largest — demands massive volumes of affordable generic ART, with our Spegra (Dolutegravir+Emtricitabine+TAF) supplementing government programme supply for private clinic patients. In Singapore and Australia, our products serve international students, skilled migrants, and tourists who need supply outside their home healthcare systems.
All products ship via DHL/FedEx with full WHO-GMP documentation, certificates of analysis, and country-appropriate import paperwork. For pricing and supply enquiries: medshopy.com or WhatsApp +91 82650 41513.
In the Philippines, our Tafero EM for HIV PrEP is increasingly sought by MSM communities in Metro Manila, Cebu, and Davao where HIV incidence among this demographic has risen sharply over the past decade. South Africa's HIV epidemic — the world's largest — demands massive volumes of affordable generic ART, with our Spegra (Dolutegravir+Emtricitabine+
All products ship via DHL/FedEx with full WHO-GMP documentation, certificates of analysis, and country-appropriate import paperwork. For pricing and supply enquiries: medshopy.com or WhatsApp +91 82650 41513.
In South Africa, how does private generic ART access complement the government HIV programme?South Africa's public ART programme — one of the world's largest — provides antiretroviral therapy free of charge to over 5 million people through the public health system. However, significant gaps remain: private sector employees with medical aid coverage may access different formulary regimens with different coverage rules; international migrants and asylum seekers may face administrative barriers to public programme enrolment; private clinic patients prefer the more discreet and convenient private healthcare setting; and stock-out or supply disruption events occasionally affect public programme continuity. For these individuals and clinics, private generic ART access fills an important gap. Affordable generic Spegra and Tafero EM from Unnati Pharmax provide equivalent clinical outcomes to what the best-resourced healthcare systems offer, at prices accessible to private South African patients and small private clinics.
